MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo study.
Wei‐Chou Lin(National Taiwan University), Kuo‐How Huang(National Taiwan University), Hong‐Chiang Chang(National Taiwan University Hospital), Yung‐Ming Jeng(National Taiwan University), Zuo-He Wang(National Taiwan University Hospital), Chih‐Kang Chiang(FIND), Chung‐Sheng Shi(Chang Gung University of Science and Technology), Shing‐Hwa Liu(National Taiwan University), June‐Tai Wu(National Taiwan University), I-Lin Ho(National Taiwan University Hospital), Tzu-Yuan Chiu(Institute of Atomic and Molecular Sciences, Academia Sinica), Wei-Shuo Chiu(National Yang Ming Chiao Tung University), Ju‐Ton Hsieh(University of Pennsylvania), Shih-Ming Liao(National Taiwan University Hospital), Chien-Tso Chou(National Taiwan University Hospital), Kuan-Lin Kuo(National Taiwan University), Shih-Chen Chang(National Taiwan University Hospital), Yeong‐Shiau Pu(National Taiwan University Hospital)
PubMed
January 1, 2015
Cited by 24
Related Papers
The MicroRNA Spectrum in 12 Body Fluids
|Clinical Chemistry|2010|2.8k
The Master Negative Regulator REST/NRSF Controls Adult Neurogenesis by Restraining the Neurogenic Program in Quiescent Stem Cells
|Journal of Neuroscience|2011|258
Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age
|British journal of surgery|2003|194
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
|eLife|2018|191
Aristolochic acid‐induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomes
|International Journal of Cancer|2013|133